The French drugs group Sanofi-Synthelabo was expected to launch its formal public bid for French-German rival Aventis yesterday, while leaving the closing date for the offer open for now.
Aventis shareholders may either sell their stock for 60.43 euros per share, or exchange six Aventis shares for five of Sanofi plus 69 euros (US$54 dollars) in cash.
The offer values Aventis at 48 billion euros (US$61 billion).
Sanofi will only go ahead with the hostile takeover bid if it is able to buy at least half of the total 802 million Aventis shares.
The offer's closing date depends on a decision by the US Federal Trade Commission (FTC) and on the outcome of current legal action in Paris.
Aventis is contesting the offer before the Paris court of appeal, which has several months to hand down a ruling.
The Franco-German group has spurned Sanofi's bid as "laughable," saying the price offered is far too low.
"They need us, we don't need them," Aventis president Igor Landau said.
He has warned Aventis shareholders that Sanofi, a smaller company currently making strong profits, wants them to bear the burden of "serious uncertainties" surrounding the predator's future prospects and research portfolio.
Sanofi chief executive Jean-Francois Dehecq said the hostile takeover of the bigger company would "speed up the growth of major products, combine marketing and commercial forces and maximize the launch of the two groups' products."
On Monday, Sanofi refused to sweeten its bid, but tried to woo Aventis shareholders by flexing its financial strength.
Sanofi posted a 17.7 percent increase in net profit to 2.076 billion euros last year from 1.759 billion euros, beating analysts' forecasts that ranged from 2.025 billion euros to 2.033 billion euros.
Analysts had forecast that Sanofi would unveil glowing results and dazzling prospects for future growth.
Looking ahead, Sanofi said it expected sales growth this year to match last year's 8.1 percent despite the unfavorable impact of currency fluctuations.
Turning to its products, Sanofi said it recorded "very positive results" from clinical trials of its anti-smoking and anti-obesity drug Rimonabant, heart treatment Dronedarone and sleep drug Ambien.
On Monday Sanofi-Synthelabo shares dipped 0.09 percent to 55.30 euros while Aventis rose 1.22 percent to 62.15 on a Paris market that closed with a gain of 0.79 percent.
NO-LIMITS PARTNERSHIP: ‘The bottom line’ is that if the US were to have a conflict with China or Russia it would likely open up a second front with the other, a US senator said Beijing and Moscow could cooperate in a conflict over Taiwan, the top US intelligence chief told the US Senate this week. “We see China and Russia, for the first time, exercising together in relation to Taiwan and recognizing that this is a place where China definitely wants Russia to be working with them, and we see no reason why they wouldn’t,” US Director of National Intelligence Avril Haines told a US Senate Committee on Armed Services hearing on Thursday. US Senator Mike Rounds asked Haines about such a potential scenario. He also asked US Defense Intelligence Agency Director Lieutenant General Jeffrey Kruse
INSPIRING: Taiwan has been a model in the Asia-Pacific region with its democratic transition, free and fair elections and open society, the vice president-elect said Taiwan can play a leadership role in the Asia-Pacific region, vice president-elect Hsiao Bi-khim (蕭美琴) told a forum in Taipei yesterday, highlighting the nation’s resilience in the face of geopolitical challenges. “Not only can Taiwan help, but Taiwan can lead ... not only can Taiwan play a leadership role, but Taiwan’s leadership is important to the world,” Hsiao told the annual forum hosted by the Center for Asia-Pacific Resilience and Innovation think tank. Hsiao thanked Taiwan’s international friends for their long-term support, citing the example of US President Joe Biden last month signing into law a bill to provide aid to Taiwan,
China’s intrusive and territorial claims in the Indo-Pacific region are “illegal, coercive, aggressive and deceptive,” new US Indo-Pacific Commander Admiral Samuel Paparo said on Friday, adding that he would continue working with allies and partners to keep the area free and open. Paparo made the remarks at a change-of-command ceremony at Joint Base Pearl Harbor-Hickam in Hawaii, where he took over the command from Admiral John Aquilino. “Our world faces a complex problem set in the troubling actions of the People’s Republic of China [PRC] and its rapid buildup of forces. We must be ready to answer the PRC’s increasingly intrusive and
STATE OF THE NATION: The legislature should invite the president to deliver an address every year, the TPP said, adding that Lai should also have to answer legislators’ questions The Chinese Nationalist Party (KMT) yesterday proposed inviting president-elect William Lai (賴清德) to make a historic first state of the nation address at the legislature following his inauguration on May 20. Lai is expected to face many domestic and international challenges, and should clarify his intended policies with the public’s representatives, KMT caucus secretary-general Hung Meng-kai (洪孟楷) said when making the proposal at a meeting of the legislature’s Procedure Committee. The committee voted to add the item to the agenda for Friday, along with another similar proposal put forward by the Taiwan People’s Party (TPP). The invitation is in line with Article 15-2